Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Chronic Hepatitis B”

Showing 5 of 0 results

Post-approval studies (Phase 4)Study completedNCT00646503
What this trial is testing

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Novartis 150
Large-scale testing (Phase 3)Study completedNCT00115245
What this trial is testing

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Large-scale testing (Phase 3)Study completedNCT01475851
What this trial is testing

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 34
Large-scale testing (Phase 3)Study completedNCT00412529
What this trial is testing

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hepatitis B
Novartis Pharmaceuticals 44
Large-scale testing (Phase 3)Study completedNCT00131742
What this trial is testing

Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation